Regeneron Pharmaceuticals (REGN) shares rose 2.8% in Thursday trading after UBS upgraded the stock to buy from neutral and raised its price target to $978 from $660 earlier.
Trading volume stood at over 557,000 shares, compared with a daily average of about 743,000.
Price: 800.39, Change: +22.03, Percent Change: +2.83
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments